Linked Life Data

8809160

Source:http://linkedlifedata.com/resource/pubmed/id/8809160

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8809160rdf:typepubmed:Citationlld:pubmed
pubmed-article:8809160lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C0038761lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C0597979lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:8809160lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:8809160pubmed:issue19lld:pubmed
pubmed-article:8809160pubmed:dateCreated1996-11-4lld:pubmed
pubmed-article:8809160pubmed:abstractTextA general method for synthesis of 2 beta-alkenyl penam sulfones has been developed. The new compounds inhibited most of the common types of beta-lactamase. The level of activity depended very strongly on the nature of the substituent in the 2 beta-alkenyl group. The inhibited species formed with the beta-lactamase from Citrobacter freundii 1205 was sufficiently stable for X-ray crystallographic studies. These, together with UV absorption spectroscopy and studies of chemical degradation, suggested a novel reaction mechanism for the new inhibitors that might account for their broad spectrum of action. The (Z)-2 beta-acrylonitrile penam sulfone Ro 48-1220 was the most active inhibitor from this class of compound. The inhibitor enhanced the action of, for example, ceftriaxone against a broad selection of organisms producing beta-lactamases. The organisms included strains of Enterobacteriaceae that produce cephalosporinases, which is an exceptional activity for penam sulfones.lld:pubmed
pubmed-article:8809160pubmed:languageenglld:pubmed
pubmed-article:8809160pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:citationSubsetIMlld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8809160pubmed:statusMEDLINElld:pubmed
pubmed-article:8809160pubmed:monthSeplld:pubmed
pubmed-article:8809160pubmed:issn0022-2623lld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:RichterH GHGlld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:AngehrnPPlld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:PageM GMGlld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:KanigKKlld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:WinklerF KFKlld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:HubschwerlenC...lld:pubmed
pubmed-article:8809160pubmed:authorpubmed-author:SpecklinJ LJLlld:pubmed
pubmed-article:8809160pubmed:issnTypePrintlld:pubmed
pubmed-article:8809160pubmed:day13lld:pubmed
pubmed-article:8809160pubmed:volume39lld:pubmed
pubmed-article:8809160pubmed:ownerNLMlld:pubmed
pubmed-article:8809160pubmed:authorsCompleteYlld:pubmed
pubmed-article:8809160pubmed:pagination3712-22lld:pubmed
pubmed-article:8809160pubmed:dateRevised2004-12-3lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:meshHeadingpubmed-meshheading:8809160-...lld:pubmed
pubmed-article:8809160pubmed:year1996lld:pubmed
pubmed-article:8809160pubmed:articleTitleDesign, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.lld:pubmed
pubmed-article:8809160pubmed:affiliationPreclinical Research, F. Hoffmann-LaRoche Ltd, Basel, Switzerland.lld:pubmed
pubmed-article:8809160pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8809160lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8809160lld:pubmed